Johns Hopkins Thoracic Oncology(@HopkinsThoracic) 's Twitter Profileg
Johns Hopkins Thoracic Oncology

@HopkinsThoracic

World class patient care and research in lung cancer, esophageal cancer, mesothelioma, and all thoracic cancers

ID:1262181220043165696

linkhttps://www.hopkinsmedicine.org/kimmel_cancer_center/centers/lung_cancer_program/ calendar_today18-05-2020 00:41:19

1,6K Tweets

1,4K Followers

139 Following

Follow People
Patrick Forde(@FordePatrick) 's Twitter Profile Photo

Concurrent immunotherapy (+ chemo) with standard radiation is not a viable approach in nsclc, now a second negative phase 3 trial after pacific 2 news.bms.com/news/corporate…

account_circle
Patrick Forde(@FordePatrick) 's Twitter Profile Photo

On right now! FDA-AACR workshop on perioperative trial designs. Great agenda in prospect through the day, livestream link below FDA Oncology AACR webcast.imsts.com/2024-05-fda-aa…

On right now! FDA-AACR workshop on perioperative trial designs. Great agenda in prospect through the day, livestream link below #lcsm @FDAOncology @AACR webcast.imsts.com/2024-05-fda-aa…
account_circle
Elsa Anagnostou(@ValsamoA) 's Twitter Profile Photo

Honored to present the first stage of theBR36 ctDNA molecular adaptive clinical trial at the CCTG plenary tonight! Thankful to all patients and BR36 investigators!
nature.com/articles/s4159…
clinicaltrials.gov/study/NCT04093…
Johns Hopkins Thoracic Oncology Cancer Research Institute

account_circle
FDA Oncology(@FDAOncology) 's Twitter Profile Photo

How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases:
AACR Past President Dr. Elizabeth Jaffee and FDA Oncology's Dr. Harpreet Singh Harpreet Singh, MD chair this AACR -U.S. FDA workshop May 9 in Bethesda, MD, or online. Learn more and sign up: aacr.org/professionals/…

How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases: AACR Past President @DrLizJaffee and FDA Oncology's Dr. Harpreet Singh @harpreet_md chair this @AACR -@US_FDA workshop May 9 in Bethesda, MD, or online. Learn more and sign up: aacr.org/professionals/…
account_circle
Patrick Forde(@FordePatrick) 's Twitter Profile Photo

Not one, not 2, but 3 lung cancer plenaries at ! Early telemed pall care, the LAURA trial of consolidation osimertinib after CRT for stage 3 EGFR non small cell lung cancer & the ADRIATIC trial of consolidation immunotherapy after CRT for small cell lung cancer!

account_circle
H. Jack West, MD(@JackWestMD) 's Twitter Profile Photo

Dr. Joshua Reuss doing a masterful job reviewing range of successes & failures of antibody-drug conjugates in lung cancer. It was at the Texas Lung Cancer meeting last year when I realized how great a communicator he is. He's again a remarkably compelling speaker.

Dr. @Joshua_Reuss doing a masterful job reviewing range of successes & failures of antibody-drug conjugates in lung cancer. It was at the Texas Lung Cancer meeting last year when I realized how great a communicator he is. He's again a remarkably compelling speaker. #TexasLung24
account_circle
Joshua Reuss(@Joshua_Reuss) 's Twitter Profile Photo

Neoadjuvant pioneer, friend and mentor Patrick Forde presenting on neoadjuvant IO in resectable NSCLC at . Impressive how a short duration of therapy can lead to improved longterm outcomes and cure!

Neoadjuvant pioneer, friend and mentor @FordePatrick presenting on neoadjuvant IO in resectable NSCLC at #TexasLung24. Impressive how a short duration of therapy can lead to improved longterm outcomes and cure!
account_circle
Susan Combs Scott, MD(@SusanScottMD) 's Twitter Profile Photo

ALK+ NSCLC best practices from Vincent Lam With 4 highly active TKIs available, we are moving toward ⬆️ precision 🎯to choose b/t them 1L and select for treatment intensification. Will we soon consider variants? 🧬 TLC Conference ALK Positive Johns Hopkins Thoracic Oncology

ALK+ NSCLC best practices from @vincentlamMD With 4 highly active TKIs available, we are moving toward ⬆️ precision 🎯to choose b/t them 1L and select for treatment intensification. Will we soon consider variants? 🧬 @TLCconference #TexasLung24 @ALKPositiveinc @HopkinsThoracic
account_circle
H.O.M.E Mentorship Initiative(@hemeoncfellow) 's Twitter Profile Photo

🚨Save the date 🚨
ASCO IMG COP IMG Oncologists - Visa, Mentorship & Advocacy Committee's webinar💥 J1 visa holders pursuing academic career💥

⏰ April 23rd, 6 PM EST

💥Guests Patrick Forde , Maya K. Khalil, MD & David Nachman
Host Mamtha Balla,MD, MPH, FACP
ASCO IMG CoP 👉bit.ly/3JmJQwK

🚨Save the date 🚨 @ASCO IMG COP @IMG_Oncologists - Visa, Mentorship & Advocacy Committee's webinar💥 J1 visa holders pursuing academic career💥 ⏰ April 23rd, 6 PM EST 💥Guests @FordePatrick , @MayaKKhalil & David Nachman Host @MamthaB ASCO IMG CoP 👉bit.ly/3JmJQwK
account_circle
Elsa Anagnostou(@ValsamoA) 's Twitter Profile Photo

Checkout our new Molecular OncologyLab website!
anagnostoulab.org
We are looking for new wet lab members to join our multi-omics and liquid biopsy efforts (research tech and post-doc level -the latter for folks with a PhD in cancer biology-), contact us if there is interest!

Checkout our new @MolecularOncLab website! anagnostoulab.org We are looking for new wet lab members to join our multi-omics and liquid biopsy efforts (research tech and post-doc level -the latter for folks with a PhD in cancer biology-), contact us if there is interest!
account_circle